Analyzing Future Trends for Medical Imaging in Clinical Trials

The use of medical imaging in clinical trials is growing. This growth coincides with current efforts by the US FDA to issue updated guidance on the use of imaging in clinical trials, the development of novel imaging biomarkers to help make go/no-go decisions, and efforts to improve the monitoring of independent image review quality using rigorous statistical methods. This 30 minute session will provide you with a unique view into the future of medical imaging in clinical trials.
  
   
Topics to be covered:

• An examination of the draft FDA guidance on imaging in clinical trials to overcome regulatory challenges
• A review of the use of tumor volumetrics and other emerging imaging biomarkers in your trial pipeline
• Monitoring of central read quality to reach beyond adjudication rates

Presenter:

Gregory V. Goldmacher, MD, PHD
Associate Director, Medical & Scientific Affairs
ICON Medical Imaging

Read Bio